HLS Hls Therapeutics

NOT FOR RELEASE IN THE UNITED STATES OR TO U.S. NEWS WIRE SERVICES.

Eurocontrol Technics Inc. (TSX VENTURE:EUO) ("Eurocontol" or the "Company"), a
Canadian public company specializing in the acquisition, development and
commercialization of innovative energy security, authentication and verification
technologies, is pleased to announce that it has entered into a definitive
agreement with Athlone Global Security Inc. ("AGS"), whereby the Company will
acquire all of the issued and outstanding common shares of AGS in exchange for
common shares and warrants of Eurocontrol Technics Ltd. (the "Transaction"). As
Eurocontrol and AGS have a director in common, being Stan Bharti and a common
officer, being Patrick Gleeson, the Transaction will be considered to be a
non-arm's length transaction for the purposes of the TSX Venture Exchange. Mr.
Bharti currently, directly or indirectly, holds 1,987,574 Eurocontrol shares and
2,600,000 AGS shares. Mr. Gleeson currently holds 15,000 AGS shares.


Pursuant to the Transaction, AGS shareholders will receive 2.4 common shares of
the Company for each share of AGS held (the "Exchange Ratio"). In addition,
holders of shares of AGS will receive one-half of one share purchase warrant
(each whole warrant a "Warrant") for each share of the Company issued. Each
Warrant shall entitle the holder thereof to acquire one common share in the
capital of the combined company at an exercise price of $0.30 for a twelve month
period following completion of the Transaction. In addition, the shareholders of
the Company will receive one-half of one share purchase warrant (each whole
warrant a "Euro Warrant") for each common share of the Company held. Each Euro
Warrant shall entitle the Eurocontrol shareholders of record on the day of
closing to acquire one common share in the capital of the combined company at an
exercise price of $0.30 for a 12 month period following completion of the
Transaction. 


Eurocontrol and Athlone have filed a joint management information circular to
provide their respective shareholders with further information regarding the
Reverse Take-Over and Related Transactions. A special meeting of Eurocontrol has
been called to consider these matters and is to be held on April 29, 2010. The
Boards of Directors of both Eurocontrol and AGS unanimously support the proposed
business combination. The Board of Directors of Eurocontrol recommends that
Eurocontrol shareholders vote in favour of the Transaction. The Board of
Directors of AGS has also recommended that the AGS shareholders vote in favour
of the Transaction. AGS has engaged Macquarie Capital Markets Canada Ltd. as its
financial advisor and sponsor with respect to the Transaction.


The proposed transactions are subject to a number of conditions, including
receipt of shareholder and regulatory approval, including approval of the TSX
Venture Exchange. 


Highlights of the Transaction

Upon completion of the Transaction, the combined company will have:



--  A uniquely diversified technology platform with complementary security
    technologies in Homeland Security (HLS), Energy Security, Authentication
    and Verification 

--  All of the AGS technologies have applications outside of the energy
    industry and serve multiple large markets.  

--  Combined company will be well positioned to integrate and further
    develop its advanced security technologies in order to capitalize on the
    growing demand for such technologies in the international marketplace. 

--  Proven management and board of directors with expertise in technology
    R&D, international market development, HLS, energy security and finance.



"Eurocontrol is very pleased to have signed our agreement with AGS and look
forward to taking this agreement to the shareholders on April 29," stated Bruce
Rowlands, President and Chief Executive Officer of Eurocontrol Technics Inc. "As
very recent incidents in Russia and the US. have demonstrated there is a growing
need globally for the types of security technologies that the
Eurocontrol-Athlone combination represents." added Mr. Rowlands.


Upon closing of the Transaction it is anticipated that a nominee of AGS will be
appointed to the board of directors of Eurocontrol.


There are currently 51,029,949 common shares of the Company issued and
outstanding. Based upon the Exchange Ratio, upon completion of the Transaction,
the resulting company will have 141,004,749 common shares issued and outstanding
and the shareholders of Eurocontrol and the shareholders of AGS will hold
approximately 36.2% and 63.8%, respectively of the common shares of the
resulting company.


About Eurocontrol Technics Inc.

Eurocontrol Technics Inc. through its wholly owned subsidiary Global Fluids
International S.A. ("GFI") is one of the world's pioneers in developing and
implementing innovative molecular marking systems for the oil industry. Through
its proprietary Petromark(TM) integral system, GFI has developed a 4-part
solution consisting of a molecular marker, injection, monitoring and control
components. Such oil industry cost realities along with GFI's 5-year R&D efforts
to create its industry-leading marking solutions, along with access to capital
provided by Eurocontrol Technics Inc. allows management to pursue numerous
anticipated oil marking opportunities in fiscal 2010 and in years to come.


About Athlone Global Security Inc.

A pioneer in the Homeland Security marketplace, Athlone Global Security Inc.
focuses on finding and investing in emerging growth companies specializing in
the development and distribution of imperative Homeland Security ("HLS") related
solutions. AGS operates principally from its offices at the in the U.S.A. and
Middle East. As a private investment group, AGS invests primarily in
technologically oriented, privately owned, and entrepreneurially managed HLS
companies that have developed unique products that can be readily adapted in
major global markets where there is great demand for these products in the
global war on terrorism. AGS' primary focus in sourcing its investment
opportunities is in Israel due to the wide breadth of opportunities available
and the strong team and infrastructure AGS has already established in Tel Aviv.
Due to the unique knowledge and expertise of counter-terrorism and HLS
technologies, Israel has become an attractive source of emerging HLS
technologies for North American and European markets. 


Please visit the Company's web site at www.athloneglobalsecurity.com.

Regulatory Footnotes

Completion of the Transaction is subject to a number of conditions, including
TSX Venture Exchange acceptance and minority shareholder approval. The
Transaction cannot close until the required shareholder approval is obtained.
There can be no assurance that the Transaction will be completed as proposed or
at all.


Investors are cautioned that, except as disclosed in the Management Information
Circular prepared by Eurocontrol in connection with the Transaction, any
information released or received with respect to the business combination may
not be accurate or complete and should not be relied upon. Trading in the
securities of Eurocontrol should be considered highly speculative.


The TSX Venture Exchange has in no way passed upon the merits of the proposed
transaction nor approved or disapproved of the contents of this news release.


This press release shall not constitute an offer to sell or solicitation of an
offer to buy the securities in any jurisdiction. The securities will not be and
have not been registered under the United States Securities Act of 1933 and may
not be offered or sold in the United States absent registration or applicable
exemption from the registration requirements. 


Cautionary Note Regarding Forward-Looking Information This press release
contains "forward-looking information" within the meaning of applicable Canadian
securities legislation. Forward-looking information includes, but is not limited
to, statements with respect to the future financial or operating performance of
each of Eurocontrol and AGS and its projects, statements regarding technological
prospects, statements regarding synergies and financial impact of the proposed
transaction, the terms and conditions of the transaction, the benefits of the
proposed transaction, costs of and capital for projects, expenditures, timing of
future technological developments, requirements for additional capital,
government regulation of industrial operations, environmental risks, title
disputes or claims, limitations of insurance coverage and the timing and
possible outcome of pending litigation and regulatory matters. Generally,
forward-looking information can be identified by the use of forward-looking
terminology such as "plans", "expects" or "does not expect", "is expected",
"budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words and phrases or
state that certain actions, events or results "may", "could", "would", "might"
or "will be taken", "occur" or "be achieved". 

Forward-looking information is subject to known and unknown risks, uncertainties
and other factors that may cause the actual results, level of activity,
performance or achievements of the Company (and the company resulting from the
successful completion of the proposed transaction) to be materially different
from those expressed or implied by such forward-looking information, including
but not limited to: general business, economic, competitive, political and
social uncertainties; the actual results of current exploration activities;
delay or failure to receive board or regulatory approvals; timing and
availability of external financing on acceptable terms; the business of AGS and
Eurocontrol and AGS not being integrated successfully or such integration
proving more difficult, time consuming or costly than expected; not realizing on
the potential benefits of the proposed transaction; conclusions of economic
evaluations; changes in project parameters as plans continue to be refined;
failure of plant, equipment or processes to operate as anticipated; accidents,
labour disputes and other risks of the industrial industry; and, delays in
obtaining governmental approvals or required financing or in the completion of
activities. Although the Company has attempted to identify important factors
that could cause actual results to differ materially from those contained in
forward-looking information, there may be other factors that cause results not
to be as anticipated, estimated or intended. There can be no assurance that such
information will prove to be accurate, as actual results and future events could
differ materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking information.
Eurocontrol and AGS do not undertake to update any forward-looking information,
except in accordance with applicable securities laws.

Hls Therapeutics (TSXV:HLS)
Historical Stock Chart
From Oct 2024 to Nov 2024

Hls Therapeutics (TSXV:HLS)
Historical Stock Chart
From Nov 2023 to Nov 2024